Free tool
FAERS Monitor: Excedrin (Migraine Relief)
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020802 or its brand name (Excedrin (Migraine Relief), Acetaminophen, Aspirin, Caffeine). Reports on generic versions are filed under their own applications.
Reports
17,178
Serious
5,166
30% of reports
Hospitalization
1,742
Death reported
250
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective3,826
- product use in unapproved indication2,064
- drug effective for unapproved indication1,573
- headache1,166
- nausea1,063
- fatigue653
- dizziness618
- migraine602
- pain546
- vomiting533
- abdominal pain upper511
- insomnia447
- diarrhoea429
- overdose420
- incorrect dose administered417
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 675 |
| 2005 | 828 |
| 2006 | 151 |
| 2007 | 119 |
| 2008 | 157 |
| 2009 | 201 |
| 2010 | 217 |
| 2011 | 413 |
| 2012 | 831 |
| 2013 | 347 |
| 2014 | 351 |
| 2015 | 637 |
| 2016 | 2,082 |
| 2017 | 2,150 |
| 2018 | 1,302 |
| 2019 | 1,071 |
| 2020 | 837 |
| 2021 | 1,321 |
| 2022 | 500 |
| 2023 | 1,053 |
| 2024 | 1,067 |
| 2025 | 521 |
| 2026 | 347 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,036,981 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug effective for unapproved indicationSignal | 1,573 | 69.4 | 66.1 | 100,464 |
| product use in unapproved indicationSignal | 2,064 | 10.3 | 9.9 | 17,330 |
| migraineSignal | 602 | 7.8 | 7.2 | 3,534 |
| drug ineffectiveSignal | 3,826 | 3.6 | 3.5 | 7,497 |
| abdominal pain upperSignal | 511 | 3.0 | 2.8 | 704 |
| overdoseSignal | 420 | 2.4 | 2.2 | 340 |
| headacheSignal | 1,166 | 2.3 | 2.2 | 860 |
| incorrect dose administeredSignal | 417 | 2.2 | 2.0 | 287 |
| insomniaSignal | 447 | 2.1 | 1.9 | 244 |
| nausea | 1,063 | 1.6 | 1.6 | 279 |
| dizziness | 618 | 1.5 | 1.4 | 111 |
| vomiting | 533 | 1.4 | 1.3 | 59 |
| pain | 546 | 1.1 | 1.0 | 4 |
| fatigue | 653 | 1.0 | 1.0 | 0 |
| diarrhoea | 429 | 0.8 | 0.7 | 19 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.